Related Experiment Videos
Impact of Elevated Blood Pressure on Cardiovascular and Cerebrovascular Outcomes in Older Adults: A
Jigar Patel1, Ronaldo Pichardo-Gonzalez1, Samantha Camp2
1Department of Internal Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.
Insights
Older adults with moderately elevated blood pressure (140-159/90-99 mmHg) had lower risks of major adverse cardiovascular events than those with severely elevated pressure (≥160/100 mmHg). However, the survival benefit was small, suggesting individualized hypertension management is crucial.
Area of Science:
- Cardiology
- Geriatrics
- Public Health
Background:
- Hypertension (HTN) management is critical for reducing cardiovascular and cerebrovascular events in older adults.
- Optimal blood pressure (BP) targets for managing HTN in the elderly remain uncertain.
- This study compares adverse event rates in older adults with different levels of elevated BP presenting to the emergency department (ED).
Purpose of the Study:
- To compare the incidence of major adverse cardiovascular events (MACE) between older adults with moderately elevated BP (SBP 140-159 mmHg, DBP 90-99 mmHg) and severely elevated BP (SBP ≥160 mmHg, DBP ≥100 mmHg) presenting to the ED.
- To evaluate the association between different BP thresholds and outcomes such as all-cause mortality, acute kidney injury (AKI), congestive heart failure (CHF), acute myocardial infarction (AMI), ischemic stroke, and hemorrhagic stroke.
Main Methods:
- Retrospective analysis of data from the Global Collaborative Network.
- Inclusion of adults aged ≥65 years with essential HTN, excluding those with end-stage renal disease.
- Comparison of two cohorts: Cohort 1 (SBP ≥160 mmHg, DBP ≥100 mmHg) and Cohort 2 (SBP 140-159 mmHg, DBP 90-99 mmHg).
- Propensity score matching was utilized to balance baseline characteristics between the cohorts.
- Primary outcome: all-cause mortality over 5 years. Secondary outcomes: AKI, CHF, AMI, ischemic stroke, and hemorrhagic stroke.
Main Results:
- After propensity score matching, 191,829 patients were included in each cohort.
- Cohort 2 (moderately elevated BP) demonstrated significantly lower risks for all primary and secondary outcomes compared to Cohort 1 (severely elevated BP).
- The largest risk differences were observed for AKI (1.28%) and ischemic stroke (1.25%).
- Absolute risk differences for all outcomes were uniformly small (<1%), including all-cause mortality (0.33%).
Conclusions:
- While a moderately elevated BP target (140-159/90-99 mmHg) showed a statistically significant reduction in adverse outcomes compared to severely elevated BP (≥160/100 mmHg), the absolute survival benefit was minimal.
- The small gains must be carefully weighed against potential risks of overtreatment, including medication costs, hypotension, and falls.
- These findings emphasize the need for individualized, risk-based hypertension management strategies in older adults.
Abstract:
Introduction: Hypertension (HTN) management is essential to improving cardiovascular and cerebrovascular morbidity and mortality in the older adult, yet optimal blood pressure (BP) targets remain uncertain. We aim to compare the incidence of major adverse cardiovascular events (MACE) among older adults presenting to the emergency department (ED) with systolic blood pressure (SBP) 140-159 mmHg and diastolic blood pressure (DBP) 90-99 mmHg versus those with SBP ≥ 160 mmHg and DBP ≥ 100 mmHg. Methods: Retrospective analysis was conducted using the Global Collaborative Network including adults aged ≥ 65 years presenting to the ED with essential HTN without end-stage renal disease. Cohort 1 (SBP ≥ 160 mmHg and DBP ≥ 100 mmHg) included older adults with more severely elevated BP, while Cohort 2 (SBP 140-159 mmHg and DBP 90-99 mmHg) included those with moderately elevated BP. The primary outcome was all-cause mortality over 5 years. Secondary outcomes included AKI, CHF, AMI, ischemic stroke, and hemorrhagic stroke. Propensity score matching was used to balance baseline characteristics. Results: After propensity score matching, 191,829 patients remained in each cohort. The mean age was 72.6 (±5.9) years; 51.8% were female, 10.5% had diabetes mellitus, and 5.65% were obese. Cohort 2 (SBP 140-159 mmHg) had lower risks across all primary and secondary outcomes compared with Cohort 1 (SBP ≥ 160 mmHg). The largest risk difference (RD) was observed for AKI (RD = 1.28%; 95% CI, 1.09-1.46%; p < 0.0001), followed by ischemic stroke (RD = 1.25%; 95% CI, 1.11-1.39%; p < 0.0001), CHF (RD = 1.11%; 95% CI, 0.93-1.29%; p < 0.0001), AMI (RD = 0.70%; 95% CI, 0.58-0.83%; p < 0.0001), all-cause mortality (RD = 0.33%; 95% CI, 0.15-0.51%; p < 0.0001), and hemorrhagic stroke (RD = 0.29%; 95% CI, 0.22-0.36%; p < 0.0001). All outcomes demonstrated consistently higher absolute risk in Cohort 1 compared with Cohort 2. Conclusion: Cohort 2 (SBP 140-159 mmHg) was associated with a statistically significant but small decrease in cardiovascular, cerebrovascular, and mortality outcomes, with all absolute RDs uniformly small (<1%) and minimal survival benefit over time. These small gains must be weighed against overtreatment risks, such as medication costs, hypotension, and falls, underscoring the need for individualized, risk-based HTN management in older adults.
Related Concept Videos
Factors affecting Blood pressure
Physiological Factors:
Pharmacodynamics in Geriatric Patients: Effects of Age
Hypertension and Regulation of Blood Pressure
Pre-Procedural Guidelines for Assessing Blood Pressure
Hypertension II: Pathophysiology
Errors occurring during blood pressure monitoring
Several factors...